Advanced search
Publication Cover
Patient Preference and Adherence Volume 17, 2023 - Issue
Submit an article Journal homepage
239
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Demographic, Physical, and Psychological Determinants of Patient Experience with Subcutaneous Self-Injection in Patients with Rheumatoid Arthritis: Structural Equation Modeling Approach

Akira Onishi1 Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan;2 Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3120-1273View further author information
ORCID Icon,
Maiko Kaizu3 Department of Nursing, Kobe University Hospital, Kobe, JapanView further author information
,
Iku Shirasugi2 Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, JapanView further author information
,
Tomoko Yagyu3 Department of Nursing, Kobe University Hospital, Kobe, JapanView further author information
,
Yo Ueda2 Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, JapanView further author information
,
Yoshitada Sakai4 Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Kobe, JapanView further author information
,
Yasushi Miura5 Department of Rehabilitation Sciences, Kobe University Graduate School of Health Sciences, Kobe, JapanView further author information
&
Jun Saegusa2 Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, JapanView further author information
 show all
Pages 1551-1559 | Received 12 Apr 2023, Accepted 30 May 2023, Published online: 03 Jul 2023

References

  • Watts R, Clunie G, Hall F, Marshall T. Rheumatology (Oxford Desk Reference). Oxford University Press; 2011.
  • Janke K, Biester K, Krause D, et al. Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data. BMJ. 2020;370:m2288. doi:10.1136/bmj.m2288
  • Hamm R, Patel B, Whittlestone T, Persad R. Patient self-injection: a new approach to administering luteinizing hormone-releasing hormone analogues. BJU Int. 2000;86(7):840–842. doi:10.1046/j.1464-410x.2000.00910.x
  • Chilton F, Collett RA. Treatment choices, preferences and decision-making by patients with rheumatoid arthritis. Musculoskeletal Care. 2008;6(1):1–14. doi:10.1002/msc.110
  • Salaffi F, Di Carlo M, Farah S, Carotti M. Adherence to subcutaneous anti-TNFα agents in patients with rheumatoid arthritis is largely influenced by pain and skin sensations at the injection site. Int J Rheum Dis. 2020;23(4):480–487. doi:10.1111/1756-185x.13803
  • Kageyama G, Onishi A, Ueda Y, et al. Subjective well-being among rheumatoid arthritis patients. Int J Rheum Dis. 2019;22(10):1863–1870. doi:10.1111/1756-185x.13704
  • Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580–1588. doi:10.1136/ard.2010.138461
  • Keininger D, Coteur G. Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ). Health Qual Life Outcomes. 2011;9(1):2. doi:10.1186/1477-7525-9-2
  • Aletaha D, Nell VP, Stamm T, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7(4):R796–806. doi:10.1186/ar1740
  • Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23(2):137–145. doi:10.1002/art.1780230202
  • Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949;140(8):659–662. doi:10.1001/jama.1949.02900430001001
  • Hair JF, Hult GTM, Ringle CM, et al. An Introduction to Structural Equation Modeling. In: Partial Least Squares Structural Equation Modeling (PLS-SEM) Using R: A Workbook. Cham: Springer International Publishing; 2021:1–29.
  • Byrne BM. Structural Equation Modeling with Amos: Basic Concepts, Applications, and Programming. 3rd ed. Routledge; 2016.
  • van den Bemt BJF, Gettings L, Domańska B, Bruggraber R, Mountian I, Kristensen LE. A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience. Drug Deliv. 2019;26(1):384–392. doi:10.1080/10717544.2019.1587043
  • Kishimoto M, Yamairi F, Sato N, Kobayashi J, Yamauchi S, Iwasaki T. Patient preference for treatment mode of biologics in rheumatoid arthritis: a 2020 web-based survey in Japan. Rheumatol Ther. 2021;8(3):1095–1111. doi:10.1007/s40744-021-00325-9
  • Serhal L, Lwin MN, Holroyd C, Edwards CJ. Rheumatoid arthritis in the elderly: characteristics and treatment considerations. Autoimmun Rev. 2020;19(6):102528. doi:10.1016/j.autrev.2020.102528
  • Lempp H, Scott D, Kingsley G. The personal impact of rheumatoid arthritis on patients’ identity: a qualitative study. Chronic Illn. 2006;2(2):109–120. doi:10.1177/17423953060020020601
  • Schiff M, Saunderson S, Mountian I, Hartley P. Chronic disease and self-injection: ethnographic investigations into the patient experience during treatment. Rheumatol Ther. 2017;4(2):445–463. doi:10.1007/s40744-017-0080-4
  • Fernandez JM, Madsen S, Krase JM, Shi VY. Classification and mitigation of negative injection experiences with biologic medications. Dermatol Ther. 2020;33(2):e13240. doi:10.1111/dth.13240
  • Doumen M, De Cock D, Pazmino S, et al. Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis. Arthritis Res Ther. 2021;23(1):269. doi:10.1186/s13075-021-02651-3
  • Bailey K, Mountian I, Bruggraber R, Sunderland K, Tilt N, Szegvari B. Patient Satisfaction with CIMZIA(®) (Certolizumab Pegol) AutoClicks(®) in the UK. Adv Ther. 2020;37(4):1522–1535. doi:10.1007/s12325-020-01257-6
  • Wray S, Armstrong R, Herrman C, et al. Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study. Expert Opin Drug Deliv. 2011;8(12):1543–1553. doi:10.1517/17425247.2011.628656

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.